HENGRUI PHARMA

1276
48.9600.73% ( -0.360 )
Delay Closed: Nov 16, 16:08:11

Financials

Q3 FY2026 Earnings

Financial report interval: 2026.06.30 - 2026.09.30

Overview: HENGRUI PHARMA(01276) the Revenue is 10.48 B (+29.04%), Beat estimate;the EBIT is 3.317 B (+107.1%), Beat estimate.

Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueExceed expectations
10.48B29.04%
10.42B28.37%
+0.05B0.67%
EBITExceed expectations
3.32B107.05%
3.01B87.93%
+0.31B19.12%
EPS
TBA--
0.325--
----

Upcoming earnings report - FY2026 Annual Earning Release

Available dateMar 25, 2027
Estimate Revenue39.53 B
Estimate EBIT--
Estimate EPS1.6058

Revenue

ActualEstimateUnit: HKD
Quarterly

EBIT

ActualEstimateUnit: HKD
Quarterly

Net income

ActualEstimateUnit: HKD
Quarterly

EPS

ActualEstimateUnit: HKD
Quarterly